tiprankstipranks
WellCell Holdings Co., Limited (HK:2477)
:2477
Hong Kong Market
Want to see HK:2477 full AI Analyst Report?

WellCell Holdings Co., Limited (2477) AI Stock Analysis

0 Followers

Top Page

HK:2477

WellCell Holdings Co., Limited

(2477)

Select Model
Select Model
Select Model
Neutral 47 (OpenAI - 5.2)
Rating:47Neutral
Price Target:
HK$5.00
▼(-59.45% Downside)
Action:Reiterated
Date:05/13/26
The score is held down primarily by weakening 2025 operating performance and sustained negative operating/free cash flow, which raises sustainability and earnings-quality risk. Technicals are modestly supportive due to the price being above major moving averages, but momentum signals are mixed. Valuation is a major headwind given the extremely high P/E and no provided dividend yield.
Positive Factors
Low leverage / strong balance sheet
A low debt-to-equity (~0.15) and a materially stronger equity base increase financial resilience. Over the next 2–6 months this reduces refinancing and solvency risk, preserves borrowing capacity for working capital or capex, and gives management time to execute operational fixes.
Negative Factors
2025 revenue and margin shock
A large 2025 decline in revenue and collapse in gross and EBIT margins represents a structural earnings reset. Such deep margin erosion reduces operating leverage, compresses cash generation potential, and may require business-model changes or pricing/cost fixes to restore sustainable profitability.
Read all positive and negative factors
Positive Factors
Negative Factors
Low leverage / strong balance sheet
A low debt-to-equity (~0.15) and a materially stronger equity base increase financial resilience. Over the next 2–6 months this reduces refinancing and solvency risk, preserves borrowing capacity for working capital or capex, and gives management time to execute operational fixes.
Read all positive factors

WellCell Holdings Co., Limited (2477) vs. iShares MSCI Hong Kong ETF (EWH)

WellCell Holdings Co., Limited Business Overview & Revenue Model

Company Description
WellCell Holdings Co., Limited, through its subsidiaries, operates as a telecommunication network support, and information and communication technology (ICT) integration services provider in the People's Republic of China. It offers telecommunicat...

WellCell Holdings Co., Limited Financial Statement Overview

Summary
Financials are pressured by a sharp 2025 operating reset (revenue -18.8%, gross margin ~4.8%, EBIT margin ~-5.5%) and the biggest risk is cash flow: operating cash flow and free cash flow were negative in both 2024 and 2025. The balance sheet is comparatively resilient with manageable leverage (debt-to-equity ~0.15), but falling ROE and weak cash conversion drag the score.
Income Statement
48
Neutral
Balance Sheet
72
Positive
Cash Flow
27
Negative
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue212.87M278.22M255.96M226.51M203.34M
Gross Profit10.15M56.72M61.61M66.70M87.58M
EBITDA-4.36M25.88M26.31M33.23M32.80M
Net Income14.94M20.14M20.40M24.26M25.52M
Balance Sheet
Total Assets330.97M325.32M183.59M163.18M149.86M
Cash, Cash Equivalents and Short-Term Investments54.95M116.58M23.81M42.20M21.54M
Total Debt31.65M43.98M28.14M30.08M8.29M
Total Liabilities115.80M124.95M98.44M82.44M78.78M
Stockholders Equity214.90M200.37M85.15M80.74M71.09M
Cash Flow
Free Cash Flow-35.01M-38.60M5.96M15.67M23.00M
Operating Cash Flow-19.79M-15.95M6.03M16.96M25.02M
Investing Cash Flow-16.81M-20.73M131.00K-1.20M-3.79M
Financing Cash Flow-14.28M117.90M-24.55M4.89M-22.82M

WellCell Holdings Co., Limited Technical Analysis

Technical Analysis Sentiment
Positive
Last Price12.33
Price Trends
50DMA
14.36
Positive
100DMA
13.70
Positive
200DMA
11.47
Positive
Market Momentum
MACD
1.94
Negative
RSI
70.58
Negative
STOCH
86.35
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:2477, the sentiment is Positive. The current price of 12.33 is below the 20-day moving average (MA) of 18.78, below the 50-day MA of 14.36, and above the 200-day MA of 11.47, indicating a bullish trend. The MACD of 1.94 indicates Negative momentum. The RSI at 70.58 is Negative, neither overbought nor oversold. The STOCH value of 86.35 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:2477.

WellCell Holdings Co., Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (60)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
76
Outperform
HK$5.77B4.659.36%6.79%0.01%4.19%
67
Neutral
HK$95.61B6.7814.46%2.86%5.18%4.25%
63
Neutral
HK$5.83B117.060.20%6.40%13.93%-533.33%
60
Neutral
$48.67B4.58-11.27%4.14%2.83%-41.78%
52
Neutral
HK$10.86B25.299.40%5.45%8.01%58.51%
47
Neutral
HK$20.76B3,222.659.59%-21.32%-23.64%
46
Neutral
HK$48.39B34.49-2.39%1.68%7.18%15.72%
* Communication Services Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:2477
WellCell Holdings Co., Limited
5.35
3.59
204.50%
HK:1310
HKBN
7.18
2.39
49.99%
HK:6823
HKT and HKT
12.65
2.01
18.91%
HK:0215
Hutchison Telecommunications Hong Kong Holdings
1.20
0.25
26.72%
HK:0315
SmarTone Telecommunications Holdings
5.15
1.04
25.40%
HK:0008
PCCW Limited
6.20
1.26
25.51%

WellCell Holdings Co., Limited Corporate Events

WellCell Redirects IPO Funds to ICT Projects and Debt Repayment
May 11, 2026
WellCell Holdings has reallocated a portion of the net proceeds from its Hong Kong share offer, shifting about RMB11 million originally earmarked for expanding project management manpower toward funding information and communication technology int...
WellCell Sets 2026 AGM to Approve Results, Board Slate and New Share Issue Mandate
Apr 23, 2026
WellCell Holdings has convened its annual general meeting for 27 May 2026 in Zhuhai, Guangdong, where shareholders will review and adopt the audited consolidated financial statements and board and auditor reports for the year ended 31 December 202...
WellCell Shareholders Approve Four-for-One Share Subdivision in Hong Kong
Apr 17, 2026
WellCell Holdings shareholders have overwhelmingly approved a share subdivision at an extraordinary general meeting held on 17 April 2026, with 100% of votes cast in favour of the proposal. The move will convert each existing share into four subdi...
WellCell Sets Out Board and Committee Structure to Bolster Governance
Apr 17, 2026
WellCell Holdings Co., Limited announced the composition of its board of directors, listing three executive directors, one non-executive director and three independent non-executive directors, led by chairman Qian Fenglei. The disclosure also clar...
WellCell Calls April 2026 EGM to Approve Share Subdivision Plan
Mar 31, 2026
WellCell Holdings Co., Limited has called an extraordinary general meeting for 17 April 2026 in Zhuhai, Guangdong, where shareholders will vote on a proposed subdivision of its ordinary shares. The move aims to increase the number of issued shares...
WellCell Holdings Posts Lower 2025 Revenue and Profit but Maintains Profitability
Mar 27, 2026
WellCell Holdings reported revenue of RMB218.5 million for 2025, down from RMB278.2 million a year earlier, with profit attributable to equity holders also declining to RMB15.3 million from RMB20.1 million. Basic earnings per share fell to RMB0.01...
WellCell Plans Four-for-One Share Subdivision on Hong Kong Listing
Mar 25, 2026
WellCell Holdings Co., Limited plans to implement a share subdivision, proposing to split each existing share of HK$0.005 into four subdivided shares of HK$0.00125, which would increase the number of issued shares from 1 billion to 4 billion while...
WellCell Schedules Board Meeting to Approve 2025 Results and Consider Final Dividend
Mar 17, 2026
WellCell Holdings Co., Limited, incorporated in the Cayman Islands and listed on the Hong Kong Stock Exchange, is overseen by a board that includes four executive directors, one non-executive director and three independent non-executive directors....
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: May 13, 2026